Newsletter

You Are in Good Hands: BOTOX® Cosmetic by Your Eye Surgeon

BOTOX® Cosmetic is the most popular cosmetic medical treatment in the US. It is favored by both men and women who are looking for non-surgical methods of skin rejuvenation. BOTOX® Cosmetic has a long history of use in ophthalmology and was first utilized by Dr. Alan B Scott, an ophthalmologist. In 1973, Dr. Scott, from the Smith Kettlewell Eye Research Institute, used botulinium toxin type A (BTX-A)experimentally to relax muscles in animals. After many years of extensive research, he officially used BTX-A for the first time in humans to treat strabismus or lazy eye. Since then, BTX-A has been used therapeutically for eyelidspastic disorders, hemifacial spasms and muscle misalignment. It is still the most effective treatment for blepharospasms, and most ophthalmologists have years of experience performing the procedure. An ophthalmologist is also the first to describe the use of BOTOX® injections for cosmetic effect. Today BOTOX® Cosmetic is a safe and effective method for reducing wrinkles and fine lines, and improving facial contours – thanks to the works of great ophthalmologists.

So how does it work? BOTOX® Cosmetic is a safe, naturally-occurring substance that can help relax the muscles around the eyes and forehead. By temporarily weakening specific muscles, your physician can soften the lines between your brows,forehead, and around the eyes. Your ophthalmologist is highly knowledgeable about the anatomy and physiology of the eyelids and face. If your frown lines have become more visible than you wish, BOTOX® Cosmetic may be the right answer for you.

Having Cataract Surgery? How to Restor® your Youthful Vision.

Cataract surgery is no longer just to help restore vision from a cloudy lens. With new advances in the development of lenses, it can be an opportunity to restore the vision one had before the need for reading glasses. A new class of multifocal intraocular lenses can be the answer to lost or forgotten glasses.

Here is how the eye loses its ability to focus at near distances: the lens sits in a bag connected to ligaments called zonules. These zonules are connected to a muscle called the ciliary muscle. The muscle and zonules flatten or condense the bag to allow light to focus on the retina. This change in the shape of the lens is called accommodation. Accommodation decreases in the mid-40s and progresses as one ages. Once cataract surgery is performed, accommodation is completely lost and patients are dependent on reading glasses at all times. With the advent of the new multifocal lenses, this accommodation can bereplicated in the design of the lenses implanted in the eye. One of the implantable lenses now available is the AcrySof® ReSTOR® IOL, which uses a unique patented apodized diffractive technology. Apodization is the gradual tapering of layered steps from the center to the outside edge of a lens in order to create a smooth transition of light between the distance, both intermediate and near focal points. Diffraction involves the bending or spreading of light as it passes through the lens. On the AcrySof® ReSTOR® IOL, the center of the lens surface is an apodized diffractive optic. This means that the series of tiny concentric steps in that center area work together to focus light for both near and distance vision. This design has been proven to help enhance patients’ lifestyles and reduce the need for glasses. Clinical studies have shown that four out of five people never wear glasses after having the lens implanted in their eyes. Additionally, there is a 94% satisfaction rate among patients with the ReSTOR® lens.

Multifocal lenses are not for everyone. If you have glaucoma, diabetes, or macular degeneration the multifocal lenses may not be an option for you. However, the surgeons at Eye Doctors of Washington will discuss in detail other options that may benefit you most.

Not the Same Old Lenses

There are more options now for astigmatic contact lens wearers than ever before. Bausch and Lomb’s Purevision Toric and Vistakon’s Acuvue Advance for Astigmatism, have been around for a couple years. These lenses are all made from silicone hydrogel materials, which are superior for their ability to transmit O2 to the ocular surface-resulting in enhanced ocular health. Recently, Vistakon and Ciba have introduced newer generation toric siliconehydrogels: the Acuvue Oasys for Astigmatism and the Ciba Air Optics for Astigmatism. The results so far are very promising.

Acuvue Oasys for Astigmatism features the exclusive Accelerated Stabilization Design and Hydraclear technology, which purports to deliver increased comfort and vision through decreased lens rotation and increased lens moisture. In addition, these lenses block more than 96% of UVA rays and 99% of UVB rays. The lenses are available in many parameters for the low to high myopes (plano to -6.00 D). Vistakon offers more specific parameters for higher myopes (-6.50 D to -9.00 D), hyperopes, or those with a high astigmatic correction. These lenses are replaced after two weeks of daily wear, though they are FDA-approved to be worn for seven days straight.

Compared to Acuvue Oasys for Astigmatism, Pure vision Torics can be worn for longer consecutive periods (one month), and O2 transmittance may approach the former lenses’ longevity. In addition, there is an excellent selection of lens parameters.

Acuvue Advance for Astigmatism is similar to the Oasys version, but it transmits O2 at lower levels. Air Optix for Astigmatism is a monthly replacement lens that, like Oasys, has been approved by the FDA for one week of extended wear. The O2 transmittance is excellent. However, it does not yet provide lenses for high myopes, hyperopes, or high astigmats.

The contact lens industry introduces new lenses frequently. Acuvue Oasys for Astigmatism stands out for its ability to provide clarity of vision without sacrificing ocular health, comfort, or convenience. Manyastigmatic contact lens wearers and eye doctors alike already prefer these lenses. Please make an appointment to discuss your candidacy for one of these excellent new lenses and see if you qualify for a FREE trial.

Do You Suffer From Dry Eyes?

Why not cure your dry eyes and earn money at the same time. Eye Doctors of Washington is conducting a research study for patients with mild to moderate dry eyes. In conjunction with Allergan, the study is comparing the effectiveness of two well-known lubricating drops already on the market. They have both been FDA-approved. To be eligible for the study you must meet the following criteria:

  • Be at least 18 years of age
  • Have mild to moderate discomfort and symptoms due to dry eyes
  • Currently use artificial tears at least twice daily
  • Come in for three quick examinations over the course of the study

If there is a reason that you do not qualify, or other ocular problems are noted, one of our highly-trained physicians will evaluate and treat your condition. If you are interested in participating in this research study, please contact our office.

Back to Top